Reuters logo
BRIEF- Viiv Healthcare files for European marketing approval for HIV drug
October 25, 2013 / 12:12 PM / 4 years ago

BRIEF- Viiv Healthcare files for European marketing approval for HIV drug

Oct 25 (Reuters) - GlaxoSmithKline Plc : * Dolutegravir trii - EU regulatory submission * Viiv healthcare announces submission for single-tablet regimen of

dolutegravir combination for HIV * Viiv healthcare ltd has GlaxoSmithkline, Pfizer Inc, and Shionogi Limited as

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below